Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT ID: NCT01279330
Last Updated: 2011-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1569 participants
INTERVENTIONAL
2010-09-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT01279278
Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer
NCT02515344
Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening
NCT03938623
General Practitioners and Participation Rate in ColoRectal Cancer Screening
NCT04492215
Influence of a Brief Intervention on CRC Screening
NCT02012829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients receive by mail the materials needed for stool samples.
Control
No intervention (Patients receive by mail the materials needed for stool samples).
Co-signed Letter
Co-signed Letter
Patients receive a personalized stimulus letter co-signed by their general practitioner and the medical coordinator of ADECA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Co-signed Letter
Patients receive a personalized stimulus letter co-signed by their general practitioner and the medical coordinator of ADECA.
Control
No intervention (Patients receive by mail the materials needed for stool samples).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not having answered the first two solicitations of ADECA75 to participate in screening for colorectal cancer
Exclusion Criteria
50 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Adeca 75
OTHER
Société de Formation Thérapeutique du Généraliste
OTHER
Hotel Dieu Hospital
OTHER
University of Paris 5 - Rene Descartes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Université Paris Descartes - Département de Médecine Générale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université Paris Descartes
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PAGEDOCC2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.